ImmunityBio Inc
ImmunityBio Inc., based in El Segundo, CA, is dedicated to advancing innovative immunotherapies aimed at empowering the human immune system to combat cancer and other diseases. The company's lead product, ANKTIVA, is designed to enhance immune response, offering targeted therapies that focus on reprogramming the immune system rather than simply treating the disease.
With a robust clinical pipeline, ImmunityBio is actively researching and developing therapies across various cancer types, including bladder cancer, glioblastoma, and HIV-related conditions. Their comprehensive approach leverages innate and adaptive immune functions to create personalized treatment solutions that promise improved safety and efficacy compared to traditional therapies.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.
